Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Tuesday July 2, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss HCC highlights from ASCO 2019.

Featured Videos

James Essell, MD, discusses the integration of stem cell transplantation in the treatment of myeloma

Andrew Cowan, MD, on the most promising clinical data in multiple myeloma presented at ASH 2019

Peter M. Voorhees, MD, explains how daratumumab is changing the way MM patients are treated today